Replies to post #179286 on Biotech Values

[DewDiligence]

(GILD)—Agreed that Tivicay + generic Truvada will likely become a popular regimen when Truvada goes generic in Jan 2018 (in the US).

[DewDiligence]

GSK—HIV drug, Tivicay is lone bright spot in dismal 2Q14:

http://www.reuters.com/article/2014/07/23/us-gsk-results-idUSKBN0FS12V20140723